SB 113 adds nabiximols (a cannabis-based medication) to South Dakota's list of Schedule III controlled substances, making it a regulated but less restricted drug classification than Schedule I or II. This change would allow the drug to be prescribed by doctors under specific conditions while maintaining state control over its distribution and use.
This bill does not directly amend codified state law.
Senate Tabled Passed, YEAS 32, NAYS 3. S.J. 196
Senate Deferred to another day S.J. 182
Judiciary Do Pass Passed, YEAS 4, NAYS 2.
Judiciary Scheduled for hearing
First read in Senate and referred to Senate Judiciary S.J. 115
Erin Tobin
Prime sponsor · Sen.
R
Sydney Davis
Prime sponsor · Rep.
R
Cosponsors
Tabled
Judiciary — Do Pass